Searchable abstracts of presentations at key conferences in endocrinology

ea0014p343 | (1) | ECE2007

The incidence of Hashimoto’s thyroiditis in the differentiated thyroid carcinoma

Voliotopoulos Vassilios , Gianakopoulos Vassilios , Valais Ioannis

Purpose: HashimotoÂ’s thyroiditis is medical disease witch affects more than 5% of the population and represents the most common cause of hypothyroidism. The possibility of an immunological and autoimmune mechanism in the pathogenia of the disease has been suggested.Methods and Materials: In 200 patients, who received iodine 131 therapy after total or near total thyroidectomy for one or more cold nodules,in our department last year (71% with papillar...

ea0014p344 | (1) | ECE2007

Thyroid cancer radioidine therapy using recombinant human TSH

Voliotopoulos Vassilios , Gianakopoulos Vassilios , Valais Ioannis

Purpose: The use of recombinant TSH (Thyrogen) has already entered in the clinical routine in order to avoid the discomfort and the morbidity associated with the withdraw of the thyroid hormone.Methods and Materials: We used the recombinant human TSH in 20 patients (age>50 years) totally or near totally thyroidectomized who came in our clinic to receive radioiodine therapy for locally invasive differentiated thyroid cancer. All patients were treated,...

ea0014p342 | (1) | ECE2007

“False negative” results of Tg in patients with DTC (differentiated thyroid carcinoma)

Voliotopoulos Vassilios , Gianakopoulos Vassilios , Valais Ioannis , Charalabidou Isaia

Purpose: The long-term monitoring of patients with differentiated thyroid carcinoma is essential throughout the patientÂ’s life after total or near total thyroidectomy followed by I-131 ablation after thyroid suppression using recombinant TSH (Thyrogen).As known the administration of rhTSH increase the sensitivity of Tg concentrations measurements. Antithyroglobulin antibodies are common clinical problem in patients with differentiated thyroid carcin...